Patients with chronic spontaneous urticaria (CSU) are widely held to often have other autoimmune disorders, including autoimmune thyroid disease. Here, we systematically evaluated the literature on the prevalence of thyroid autoimmunity in CSU and vice versa. There is a strong link between CSU and elevated levels of IgG antithyroid autoantibodies (AAbs), with most of a large number of studies reporting rates of ≥10%. Levels of IgG against thyroid peroxidase (TPO) are more often elevated in CSU than those of other IgG antithyroid AAbs (strong evidence). Levels of IgG antithyroid AAbs are more often elevated in adult patients with CSU than in children (strong evidence). Patients with CSU exhibit significantly higher levels of IgG antithyroid AAbs (strong evidence) and IgE-anti-TPO (weak evidence) than controls. Elevated IgG antithyroid AAbs in CSU are linked to the use of glucocorticoids (weak evidence) but not to disease duration or severity/activity, gender, age, or ASST response (inconsistent evidence). Thyroid dysfunction rates are increased in patients with CSU (strong evidence). Hypothyroidism and Hashimoto's thyroiditis are more common than hyperthyroidism and Graves' disease (strong evidence). Thyroid dysfunction is more common in adult patients with CSU than in children (strong evidence) and in female than in male patients with CSU (weak evidence). Urticaria including CSU is more prevalent in patients with thyroid autoimmunity than in controls (weak evidence). CSU can improve in response to treatment with levothyroxine or other thyroid drugs (strong evidence). Pathogenic mechanisms in CSU patients with thyroid autoimmunity may include IgE against autoantigens, immune complexes, and complement.
from hypothyroidism or euthyroidism in Hashimoto's thyroiditis (HT, also known as chronic autoimmune thyroiditis and autoimmune hypothyroidism) to hyperthyroidism in Graves' disease (GD). Both conditions are characterized by infiltration of the thyroid by T and B cells reactive to thyroid antigens and formation of autoantibodies against thyroid peroxidase (TPO), thyroglobulin (TG), and/or thyroidstimulating hormone (TSH) receptor (anti-TSHr). 9, 11 Recently, some studies have reported on the prevalence of urticaria including CSU in AITD patients. [12] [13] [14] [15] In 1907, at the VI International Dermatological Congress in New York, Ravitch suggested for the first time an association between CSU and thyroid disease and discussed the effects of thyrotherapy on urticaria symptoms. 16 The notion that both diseases are linked was further supported in 1968 by Rothfeld, who reported urticaria in three of 108 patients with hyperthyroidism. In two of them, "urticaria and pruritus seemed to vary with thyroid status". 17 Later, Juhlin and Thune and Granholt found thyroid disease in 6% and 4% of patients with recurrent urticaria, respectively. 18, 19 That chronic urticaria and thyroid disease in the same patient may be related to a common autoimmune phenomenon was originally postulated in 1971 by Isaacs. He described the clinical course of four patients with hyperthyroidism and chronic urticaria, in which controlling the hyperthyroid state cleared their urticaria. 20 Since then, a large number of studies on the comorbidity of CSU and thyroid autoimmunity have been conducted worldwide. Here, we systematically evaluated the literature on the prevalence of thyroid autoimmunity in CSU and vice versa, and we provide a structured review of the evidence for a causal and pathogenetic association of CSU with AITD.
2 | ME TH ODS
| Search strategy
A PubMed search was performed to identify reports published from 1960 to December 2016 with the keywords "urticaria" in combination with the terms "thyroid," "TG," "TPO," "thyroglobulin," and "per- 
| Selection and assessment of relevant studies
Using a hierarchical approach, we first screened titles and then abstracts of the publications identified by our search strategy for potentially relevant studies, after which full texts were assessed. This approach identified 240 studies, of which 138 were excluded from further analysis after review of the title and the abstract: irrelevant publications (n=111), reviews (n=8), case reports (n=13), reports on the same results from the same team (n=3), and publications where the data were not clearly described (n=3). The remaining 102 studies were included in the systematic review. We also examined the reference lists of the retrieved articles to identify additional studies (n=67).
Reported data on cases of acute urticaria were excluded. Similarly, reports on patients with chronic inducible urticaria were excluded whenever possible. Some studies, however, did not differentiate clearly between CSU and chronic inducible urticaria. These studies are included in Tables 1-8 , but are marked to be easily identified.
The following information was extracted from each study report when possible: the first author, published year, region of study population, design of study, age of patients and controls, number of patients and controls, frequency of antithyroid AAbs, Graves' disease (GD), Hashimoto's thyroiditis (HT), hypothyroidism and hyperthyroidism, and efficacy of antithyroid drugs or replacement treatment with levothyroxine in regard to CSU symptoms.
Hypothyroidism is defined as a serum TSH level above the upper limit of normal values and normal (subclinical hypothyroidism) or decreased (overt or clinical hypothyroidism) levels of serum free thyroxine (T4). Hyperthyroidism is defined as a serum TSH level below the lower limit of normal values and normal (subclinical hyperthyroidism) or elevated (overt or clinical hyperthyroidism) levels of serum free T4. 21 
| Assessment of quality of evidence and strength of associations
The links between CSU and AITD were assessed using a rating system as previously described. 22 Based on the outcome and number of studies, we categorized the levels of scientific evidence for "association" as follows:
• strong: three studies available that find an association in the same direction or ≥4 studies available, of which more than two-thirds find an association in the same direction and no more than 25%
find an opposite association;
• weak: two studies available that find an association in the same direction or three studies available, of which two find an association in the same direction and the third study finds no association;
T A B L E -, no data, not defined in the paper or in the abstract; AAbs, autoantibodies; CC, case-control study; P, prospective study; R, retrospective study; CS, cross-sectional study; D, descriptive study; TPO, thyroid peroxidase; TG, thyroglobulin; CSU, chronic spontaneous urticaria. anti-TPO is not significantly associated with thyroid disease in the general population.
21
IgG-anti-TSHr
In six independent studies (Table 2) , the prevalence of elevated IgGanti-TSHr in patients with CSU was 0%-83.3%. Five of six studies reported rates of <10%. Thus, in most of the analyzed studies in patients with CSU, the prevalence of IgG antithyroid AAbs in children is lower than in adults.
Adult patients with CSU vs children with CSU
In several population-based studies, the prevalence of autoimmune thyroiditis in children was 0.35%-1.6%. [24] [25] [26] This low prevalence of thyroid autoimmunity in children compared to adults can be explained by data that the likelihood of having an autoimmune disease including AITD increases with age. 9, 13, 21, 27 Thyroid pathology, including AITD, does not appear to be an important associated and/or etiological factor of CSU in children. [28] [29] [30] [31] In this perspective, several environmental triggers and age-related mechanisms, such as prolonged inflammation and/or increased oxidative stress, may accumulate over the years, favoring the development of other autoimmune disorders in CSU and AITD.
13,32
• There is a strong link between CSU and elevated levels of IgG antithyroid AAbs (strong evidence).
• Levels of IgG-anti-TPO are more often elevated in CSU than those of other thyroid AAbs (strong evidence).
• Levels of IgG antithyroid AAbs are more often elevated in adult patients with CSU than in children (strong evidence).
| As compared to controls, do patients with
CSU exhibit higher levels of IgG antithyroid autoantibodies, and are elevated levels more common?
CSU vs controls
In 29 studies, the blood levels of IgG antithyroid AAbs and rates of elevated levels were compared in patients with CSU and healthy controls (HCs) or control subjects without urticaria (Table 3) . Thus, patients with CSU exhibit significantly higher levels of IgG antithyroid AAbs than controls. This is in support of the results of a recent meta-analysis and a study with data on 12,778 patients and 10,714 controls.
27,34

CSU vs other diseases
No significant difference in the prevalence of elevated IgG-anti-TG and/or IgG-anti-TPO was observed between patients with CSU and patients with acute urticaria, 35, 36 urticarial vasculitis, 37 rheumatoid arthritis, or systemic lupus erythematosus. 38 In contrast, some studies showed that patients with CSU had • Patients with CSU exhibit significantly higher levels of IgG antithyroid AAbs than controls (strong evidence).
| What is the prevalence of elevated IgE thyroid autoantibodies in CSU?
The rates of elevated IgE-anti-TPO and IgE-anti-TG in patients with CSU were investigated by five and two studies, respectively, and ranged from 0% to 54.2% (Table 4 ). In HCs, the prevalence of IgEanti-TPO and IgE-anti-TG was 0% as reported by three studies. Two of six studies showed that serum levels of IgE-anti-TPO are significantly higher in patients with CSU than in normal subjects. Two studies failed to reproduce an association between IgE antithyroid AAbs and CSU.
The prevalence of these AAbs in the general population has not yet been evaluated in detail. Guo et al. 44 provided evidence for the presence of low-titer IgE-anti-TPO in patients with AITD using a very sensitive IgE capture assay.
There was no significant association between the prevalence of IgE-anti-TPO and IgG-anti-TPO in one study, 36 but such an association was demonstrated in another. 45 • Patients with CSU exhibit significantly higher levels of IgE-anti-TPO than controls (weak evidence).
| Association between the presence of thyroid autoantibodies and CSU parameters
A total of 60 studies evaluated the association of IgG antithyroid AAbs and various clinical and laboratory features of CSU (Table 5 ).
Our review of these studies identified weak evidence in support of an association of elevated IgG antithyroid AAbs and more frequent glucocorticosteroid use. The evidence for other parameters, for example, CSU duration, severity/activity, and ASST response, is inconsistent or nonexistent.
We found inconsistent evidence for an association of IgG antithyroid AAbs with the gender and age of patients with CSU.
However, many large population-based studies and reviews reported that the prevalence of IgG antithyroid AAbs, AITD, and/or thyroid dysfunction increases with age and is higher in healthy women and in women without CSU compared to men. 
Canada
-, no data, not defined in the paper or in the abstract; CC, case-control study; P, prospective study; R, retrospective study; D, descriptive study; CSU, chronic spontaneous urticaria. 
Thyroid dysfunction
In 41 independent studies, the prevalence of thyroid dysfunction (hypothyroidism and/or hyperthyroidism) in patients with CSU ranged from 0% to 54.5% (Table 6 ). Thirty-two of 41 studies (76%), 25 of 41 studies (61%), and 20 of 41 studies (49%) reported thyroid dysfunction rates of ≥2%, ≥5%, and ≥10%, respectively.
Hypothyroidism vs hyperthyroidism
Specifically, 0%-42.6% and 0%-31% of patients with CSU showed clinical and subclinical hypothyroidism, respectively, whereas clinical hyperthyroidism was reported in 0%-17.6% and subclinical hyperthyroidism in 0%-5.5% of patients. Almost half of these studies demonstrated clinical and subclinical hypothyroidism in ≥5% of patients (44%, 17/41 of studies; and 40%, 6/15 of studies, respectively). In contrast, only 16% (5/32) and 8% (1/13) of studies showed clinical and subclinical hyperthyroidism, respectively, in ≥5% of patients. The prevalence of hypothyroidism and hyperthyroidism in the general population is 3.05%-4.6% and 0.75%-1.3%, respectively.
21,47
These findings indicate that in CSU, hypothyroidism is more common than hyperthyroidism. This is further supported by the fact that 58% of studies (18 of 31) found higher rates of hypothyroidism than hyperthyroidism, as compared to only 13% of studies (4 of 31)
reporting higher rates of hyperthyroidism than hypothyroidism.
Moreover, hypothyroidism or subclinical hypothyroidism was more frequent than hyperthyroidism in a large sample of 12,778 patients with CSU. 27 In most studies (three of five), but not all studies, 48, 49 patients with CSU were found to have significantly higher rates of hypothyroidism 27,50,51 and hyperthyroidism 27,50 than HCs and patients without CSU.
Adult patients with CSU vs children with CSU
In adult patients with CSU (≥18 years old, 20 studies), clinical hypothyroidism and clinical hyperthyroidism were found in 0%-42.6% and 0%-13.8%, respectively. Eleven of 20 studies (55%) and only 3 of 15 studies (20%) reported rates of ≥5% for clinical hypothyroidism and clinical hyperthyroidism, respectively. The prevalence of clinical hypothyroidism and clinical hyperthyroidism in children with CSU (<18 years) was much lower: from 0% to 1.1% (five studies) and 0% (four studies), respectively.
Graves' disease vs Hashimoto's thyroiditis
The reported rates of CSU patients with GD ranged from 0% to 9.1% and for HT from 0.5% to 27.5%. These are higher than reported for the general population with 0.4%-1.5% (GD) 5-8 and 0.9%-9.1% (HT). 9 Rates of GD in CSU were ≥5% in one of eight studies, and rates of HT were ≥5% in 9 of 16 studies. In all six of six studies, rates of HT were higher than those of GD. This indicates that patients with CSU have a higher prevalence of HT than GD.
IgG antithyroid AAbs and thyroid dysfunction in CSU
Although both hyper-and hypothyroidism are associated with CSU, some patients with antithyroid AAbs are asymptomatic with normal or slightly abnormal thyroid function. 52, 53 Hollowell et al. 21 reported that elevated levels of IgG-anti-TPO, but not IgG-anti-TG, are significantly associated with hypothyroidism and hyperthyroidism. Elevated One of the control subjects had autoimmune thyroiditis and two others had allergic rhinitis. *Statistically significant association with a P-value <.05.
T A B L E 4 Serum IgE thyroid AAb reactivity in patients with CSU and controls measured by immunoassays
KOLKHIR ET AL.
| 1449 as well as in the general population 9 increases with age. In >80% of patients with CSU, thyroid dysfunction was diagnosed within 10 years of the diagnosis of CSU. 27 Thus, annual reassessment of thyroid function in CSU patients with elevated IgG antithyroid AAb levels may be warranted and is recommended by some urticaria specialists. 55 
T A B L E 6 Prevalence of thyroid diseases in CSU
Women with CSU vs men with CSU
The frequency of thyroid dysfunction (hyperthyroidism and/or hypothyroidism) in women with CSU is significantly higher than in men. 27, 56 Females in the general population were also shown to have a greater risk of having hypothyroidism and AITD (both Hashimoto's thyroiditis and Graves' disease) than men.
9,21,46
Patients with CSU vs HCs
In two studies, 57, 58 but not all studies, 38, 49 patients with CSU had significantly higher rates of thyroid dysfunction compared to HCs. 45 In other studies, a direct ELISA approach 36, 59, 60 was carried out, where IgG AAbs to the antigen can mask the presence of IgE AAbs due to competition. 61 IgG-anti-TPO and IgG antimicrosomal antibodies are the same type of autoantibody, and some papers referring to the latter may have used passive hemagglutination instead of immunometric methods. 23, 34, 62 Moreover, a small minority of patients with AITD may have no detectable
Limitations
IgG-anti-TPO/TG. 34 In some older studies, antithyroid AAbs were not investigated, and patients with CSU were labeled as having "thyroid disease". 19 In other studies, the diagnosis of chronic urticaria was solely based on the patient history, and not confirmed by a medical specialist. 63 There is substantial geographic variation in the diagnosis of AITD, both GD and HT, maybe because of environmental and/or genetic factors. 9 For example, iodine-sufficient populations appear to have higher incidences of hypothyroidism and more thyroiditis compared to those that are iodine-deficient. 9 In addition, the prevalence of IgG antithyroid AAbs is greater in Caucasian and
Mexican Americans than in African Americans. 9, 21 At last, preclinical and clinical thyroid disease definitions and terminology are nonstandardized.
• Thyroid dysfunction rates are increased in patients with CSU (strong evidence).
• Hypothyroidism and Hashimoto's thyroiditis are more common than hyperthyroidism and Graves' disease (strong evidence).
• Thyroid dysfunction is more common in adult patients with CSU than in children (strong evidence).
• Thyroid dysfunction is more common in female than in male patients with CSU (weak evidence).
| What is the prevalence of urticaria including CSU in patients with thyroid disease?
Little is known about the prevalence of CSU in thyroid diseases.
Most studies fall short on differentiating CSU from acute urticaria, inducible urticaria, and/or urticarial vasculitis. In 19 independent 1982
-, no data, not defined in the paper or in the abstract; CC, case-control study; P, prospective study; R, retrospective study; CS, cross-sectional study; D, descriptive study; CSU, chronic spontaneous urticaria. | 1451 studies (Table 7) , the prevalence of urticaria including CSU in patients with thyroid disease including AITD ranged from 0.4% to 56.7%. In all but two studies, the prevalence of urticaria including CSU was found to be >1% (1% is believed to be the prevalence of CSU in the general population).
2
Two of three studies that directly compared AITD patients and controls including HCs showed a higher prevalence of urticaria including CSU in AITD patients; 63,64 one study did not. 65 Only one of four studies showed a higher rate of urticaria including CSU in patients with AITD as compared to patients with nonautoimmune thyroid diseases; 63 the other three did not. 49, 64, 66 No difference in the prevalence of urticaria including CSU in hypothyroid and hyperthyroid patients was demonstrated compared to HCs. 64 However, Saadia et al. 67 found that hypothyroid women, as compared to euthyroid women, showed significantly higher rates of urticaria and puffiness of hands and feet.
• Urticaria including CSU is more prevalent in patients with AITD than in controls (weak evidence).
| Efficacy of treatment with thyroid drugs on CSU symptoms
A total of 22 studies assessed the effects of thyroid medication including levothyroxine (n=16), methimazole (n=2), propylthiouracil (n=2), and triiodothyronine (n=1) on CSU (Table 8) . For seven
T A B L E 7 Prevalence of urticaria including CSU in patients with thyroid diseases
First author of the study (reference) Year Age (y)
Patients with thyroid diseases % (n/total) controls with urticaria including CSU Design Country n, total % (n) with urticaria including CSU studies, the drug that was used for the treatment was not specified in the publication.
Of 285 patients treated with thyroid medication, CSU was improved in 120 (42%) patients. Fourteen studies reported complete remission of CSU in 68 patients (24%) and partial improvement in 28 patients (10%). 28, 32, 53, 56, 60, [68] [69] [70] [71] [72] [73] [74] [75] [76] Beneficial effects were not specified in 24 (8%) of 285 patients in two studies and were not seen in six studies in all patients. In total, 182, 85, and 18 patients were hypothyroid, euthyroid, and hyperthyroid, respectively. Treatment of hypothyroidism (n=182 patients, 17 studies), euthyroid CSU patients (n=85 patients, 10 studies), and hyperthyroidism (n=18 patients, six studies) led to improvement or remission of CSU in 28% (n=51 patients, 12 studies), 67% (n=57 patients, eight studies), and 67% (n=12 patients, four studies) of patients, respectively. In five of 17, two of 10, and two of six studies, treatment of hypothyroidism, euthyroid CSU patients, and hyperthyroidism, respectively, had no effect on CSU in any of 64, 4, and 6 patients.
Patients with CSU in four studies were treated for HT or GD.
Urticaria improved in 24 of 34 (70.6%) CSU patients with HT and in five of 10 (50%) CSU patients with GD. 56, 69, 74, 75 First effects of levothyroxine treatment on CSU were seen after 3-12 weeks. 68, 69, 77 According to one study, CSU symptoms decreased within 2 months after the start of treatment of hyperthyroidism with thiourea drugs. M, treated with methimazole; P, treated with propylthiouracil; L, treated with levothyroxine; T, treated with triiodothyronine; -, no data, not defined in the paper or in the abstract; CC, case-control study; P, prospective study; R, retrospective study; CSU, chronic spontaneous urticaria.
a During the treatment, a significant reduction in UAS was observed in hypothyroid CSU subjects. However, the mean UAS after 3 and 6 months of Lthyroxine treatment remained not significantly different from that in control euthyroid subjects with CSU b It is not clear from the paper whether patients with inducible urticaria were excluded. efficacy, the speed of effect, and numbers of patients with partial improvement and remission of CSU were not described. In some cases, levothyroxine was used in combination with other drugs such as antihistamines. 68 Moreover, no randomized double-blind, placebocontrolled studies are available. 79 Of importance may be the fact that spontaneous remission may occur in up to 50% of patients with CSU. 80, 81 For instance, in one study, the mean Urticaria Activity
Score after 3 and 6 months of levothyroxine treatment was not significantly different in hypothyroid CSU patients than in control untreated euthyroid subjects with CSU and without antithyroid AAbs. 81 In addition, hyperthyroidism per se 82 and antithyroid drugs themselves may be a cause of itch or urticaria.
The results of our analysis do not indicate that the use of thyroxine treatment is beneficial in euthyroid CSU patients, at least until data from well-controlled studies provide evidence for this. Selected CSU patients with hypo-or hyperthyroidism, however, may benefit from treatment with levothyroxine or other thyroid drugs, respectively.
• CSU can improve in response to treatment with levothyroxine or other thyroid drugs (strong evidence).
• CSU in hyperthyroid and euthyroid patients is more likely to respond to such treatment than in hypothyroid patients (strong evidence). Several potential mechanisms whereby infectious agents may trigger both AITD and CSU have been hypothesized. 79 Helicobacter pylori infection has been linked to CSU and AITD in some studies but not in others. [97] [98] [99] For example, Bakos and Hillander 100 found a high prevalence of IgG and IgA antibodies to 19-kDa H. pylori-associated lipoprotein in CSU. An association between H. pylori infection and IgG antithyroid AAbs in CSU has been proposed based on the reactivity and molecular similarity of antibodies against H. pylori and TPO. 79, 99 Staphylococcus aureus superantigens were shown to activate MCs and basophils to release proinflammatory mediators and cytokines. 101, 102 Moreover, Wan et al. 103 described the adoptive transfer of experimental autoimmune thyroiditis in mice based on staphylococcal enterotoxin A superantigen stimulation of thyroglobulin-primed cells.
|
A role of hepatitis C virus infection in the etiology and pathogenesis of both urticaria and AITD has been suggested. 79, 104 Recently, some studies have shown high levels of IgE AAbs such as IgE-anti-TPO and IgE-anti-dsDNA in the blood of patients with CSU. 36, 45, 59 These IgE autoantibodies are held to be relevant for the pathogenesis of CSU in a subpopulation of patients. 3 IgE-anti-TPO autoantibodies, when bound on the surface of mast cells and basophils, could cause "autoallergic" activation and degranulation of cells, 36 after exposure to the specific circulating antigen, which is released as a result of autoimmune thyroid damage. 105 The hypothesis that IgE AAbs including IgE-anti-TPO can induce CSU symptoms is further supported by the analogy with acute urticaria due to IgE-mediated hypersensitivity, 106 • Are chronic inducible urticaria and urticarial vasculitis also linked to thyroid autoimmunity?
F I G U R E 2 Possible pathogenetic relationship between chronic spontaneous urticaria and autoimmune thyroid diseases. IgE-anti-TPO/TG autoantibodies, when bound on the surface of basophils, could cause "autoallergic" activation and degranulation of cells probably after exposure to the specific extracutaneous thyroid autoallergens such as TPO and/or TG, which are released into the circulation as a result of autoimmune thyroid damage. IgG antithyroid AAbs do not seem directly involved in the MCs degranulation but may be enhancing factor of MCs sensitivity. TSH might drive the production of proinflammatory cytokines by lymphocytes and monocytes that induce the synthesis of IgG antithyroid AAbs. The inflammation, caused by the presence of IgG antithyroid AAbs, disrupts the normal architecture of the gland and leads to release of sequestered autoantigens, which induce a low-grade autoimmune response. Products of this autoimmune response such as thyroid protein immune complexes activate classical complement pathway, leading to generation of C3a and C5a, which cause degranulation of mast cells. Inflammatory response in the thyroid gland might lead to a generalized inflammatory state and lowers the threshold of MCs to other stimuli. TPO, thyroid peroxidase; TSH, thyroid-stimulating hormone; TG, thyroglobulin; CICs, circulating immune complexes
